Remaining Challenges in the Treatment of HER2-Positive Breast Cancer


In the first segment, Dr Mahtani and colleagues outline challenges and remaining unmet needs in the management of patients with HER2-positive breast cancer.

Related Videos
Wesley J. Talcott, MD, MBA
Judy C. Boughey, MD
Francisco J. Esteva, MD, PhD
Stephanie L. Graff, MD
Related Content